December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

A New Question for Chronic Pain

A new clinical feature–based self-referral tool shows promise for speeding the diagnosis of axial spondyloarthritis.

Conexiant

December 05, 2025

Top 10 States to Practice Rheumatology

The following list highlights the states that offer the most favorable conditions for rheumatologists.

Conexiant

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 18, 2025

'Integrity Cannot Be Replaced': Ousted CDC Leader Speaks Out

Testimony from former CDC leadership highlighted differences with federal health officials on the process for reviewing and implementing vaccine policies.

KFF Health News

November 26, 2024

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

A recent study reveals significant treatment response improvements in severe psoriatic arthritis and extensive psoriasis, emphasizing the need for personalized treatment strategies and sensitive outcome measures. (Source: Psoriatic Arthritis Research Consortium)

Conexiant